📰 Cell Gene News
Page 2 - Cell Gene News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Gene. Real-time updates on events, politics, business and more.
May 6, 2021
Supporting Multiple Global Gene Therapy Studies For Rare Diseases A long-term client called upon the Veristat team for help conducting two investigational Phase I/II studies. These global studies focused on proving the safety and efficacy of gene therapy for two rare genetic disorders. Working side-by-side with the client, our cell and gene therapy experts addressed many complicated challenges – including site start-up issues, stringent regulatory requirements, and the logistics of handling h...
April 21, 2021
Share this article Share this article ResearchAndMarkets.coms offering. The Global Leukemia Therapeutics Market was valued USD18584.23 Million in 2020 and is expected to grow at a CAGR of 7.47% during the forecast period. The Global Leukemia Therapeutics Market is driven by the technological advancements and innovations in the field of blood cancer testing on account of the growing number of patients suffering from leukemia. Additionally, growing awareness among the population pertaining to ad...
March 1, 2021
Pharmaron Beijing Co., Limited: Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie Continues to build integrated capabilities platform for Cell Gene Therapy Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ("Pharmaron") announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited ("The ABL site") in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the s...
January 7, 2021
Share this article Share this article ResearchAndMarkets.coms offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as "living drugs." T-cells form the backbone of CAR-T cell therapy. T-cells are the workhorses of our immune s...